Exchange Agreements
Biotechnology
Biotechnology (504) | Exchange Agreements (7,629)
- 89bio, Inc. (1 contract)
- ABEONA THERAPEUTICS INC. (2)
- ACCELERON PHARMA INC (6)
- Achaogen, Inc. (2)
- Acorda Therapeutics (1)
- Actinium Pharmaceuticals, Inc. (2)
- ADiTx Therapeutics, Inc. (3)
- ADMA BIOLOGICS, INC. (9)
- Advaxis, Inc. (7)
- AGENUS INC (10)
- AGIOS PHARMACEUTICALS INC (5)
- AILERON THERAPEUTICS INC (3)
- Aimmune Therapeutics, Inc. (2)
- Akebia Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (2)
- Allarity Therapeutics, Inc. (1)
- Alliqua BioMedical, Inc. (2)
- ALNYLAM PHARMACEUTICALS, INC. (2)
- ALPINE IMMUNE SCIENCES, INC. (1)
- Altimmune, Inc. (5)
- Amgen Inc. (5)
- AMICUS THERAPEUTICS, INC. (1)
- AmpliPhi Biosciences Corp (4)
- ANAVEX LIFE SCIENCES CORP. (1)
- Apellis Pharmaceuticals, Inc. (6)
- AQUINOX PHARMACEUTICALS, INC (2)
- Arbutus Biopharma Corp (5)
- ARENA PHARMACEUTICALS INC (1)
- ARROWHEAD PHARMACEUTICALS, INC. (7)
- Athenex, Inc. (1)
- aTYR PHARMA INC (1)
- AVEO PHARMACEUTICALS INC (2)
- BeiGene, Ltd. (9)
- BICYCLE THERAPEUTICS Ltd (2)
- BioCardia, Inc. (1)
- BIOCRYST PHARMACEUTICALS INC (2)
- Biohaven Pharmaceutical Holding Co Ltd. (1)
- BioNexus Gene Lab Coporation (1)
- BioRestorative Therapies, Inc. (8)
- BIOTIME INC (2)
- BIOXYTRAN, INC (1)
- BRAINSTORM CELL THERAPEUTICS INC. (2)
- CareDx, Inc. (1)
- CASI Pharmaceuticals, Inc. (4)
- CATALYST BIOSCIENCES, INC. (1)
- Cell Source, Inc. (2)
- Celldex Therapeutics, Inc. (2)
- Cellectar Biosciences, Inc. (3)
- Celsion CORP (1)
- CEREBAIN BIOTECH CORP. (1)
- Chanticleer Holdings, Inc. (4)
- ChemoCentryx, Inc. (2)
- Cidara Therapeutics, Inc. (1)
- Clovis Oncology, Inc. (2)
- Conatus Pharmaceuticals Inc. (2)
- Corvus Pharmaceuticals, Inc. (1)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
- CTI BIOPHARMA CORP (6)
- Cullinan Oncology, LLC (1)
- CURIS INC (9)
- Cyclacel Pharmaceuticals, Inc. (2)
- Day One Biopharmaceuticals Holding Co LLC (1)
- DelMar Pharmaceuticals, Inc. (2)
- Dermavant Sciences Ltd (1)
- Digital Development Partners, Inc. (6)
- DYNAVAX TECHNOLOGIES CORP (1)
- Edge Therapeutics, Inc. (2)
- Emergent BioSolutions Inc. (5)
- Enanta Pharmaceuticals, Inc. (7)
- ENDONOVO THERAPEUTICS, INC. (2)
- Enochian Biosciences Inc (1)
- ENZOLYTICS INC (1)
- ENZON PHARMACEUTICALS, INC. (1)
- Epizyme, Inc. (2)
- Esperion Therapeutics, Inc. (1)
- Fibrocell Science, Inc. (1)
- Fortress Biotech, Inc. (2)
- Gain Therapeutics, Inc. (1)
- GALECTIN THERAPEUTICS INC (1)
- Gene Biotherapeutics, Inc. (2)
- GENOCEA BIOSCIENCES, INC. (8)
- GeoVax Labs, Inc. (2)
- GERON CORP (1)
- Greater Cannabis Company, Inc. (3)
- GT Biopharma, Inc. (3)
- HEAT BIOLOGICS, INC. (2)
- HedgePath Pharmaceuticals, Inc. (2)
- HERON THERAPEUTICS, INC. (1)
- HISTOGENICS CORP (1)
- HST Global, Inc. (4)
- iBio, Inc. (1)
- IMMUNE PHARMACEUTICALS INC (2)
- Immune Therapeutics, Inc. (2)
- ImmunoCellular Therapeutics, Ltd. (4)
- IMMUNOGEN INC (3)
- IMMUNOMEDICS INC (2)
- INFINITY PHARMACEUTICALS, INC. (4)
- INOVIO PHARMACEUTICALS, INC. (1)
- INSMED Inc (3)
- Inspyr Therapeutics, Inc. (2)
- INTERCEPT PHARMACEUTICALS, INC. (6)
- International Stem Cell CORP (3)
- Invitae Corp (1)
- IOVANCE BIOTHERAPEUTICS, INC. (8)
- Kadmon Holdings, Inc. (1)
- Karyopharm Therapeutics Inc. (1)
- Kindred Biosciences, Inc. (1)
- Kiromic Biopharma, Inc. (1)
- LA JOLLA PHARMACEUTICAL CO (1)
- Ligand Pharmaceuticals Incorporated (1)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- MACROGENICS INC (14)
- MARIZYME INC (1)
- MATEON THERAPEUTICS INC (1)
- MERRIMACK PHARMACEUTICALS INC (3)
- Mersana Therapeutics, Inc. (1)
- MiMedx Group, Inc. (2)
- MIRAGEN THERAPEUTICS, INC. (2)
- Molecular Templates, Inc. (1)
- Momenta Pharmaceuticals, Inc. (3)
- Monte Rosa Therapeutics, Inc. (2)
- NANOVIRICIDES, INC. (2)
- NAVIDEA BIOPHARMACEUTICALS, INC. (5)
- NextCure, Inc. (8)
- NORTHWEST BIOTHERAPEUTICS INC (2)
- NOVAVAX INC (13)
- Novus Therapeutics, Inc. (5)
- Nuo Therapeutics, Inc. (3)
- OncBioMune Pharmaceuticals, Inc (4)
- ONCOSEC MEDICAL Inc (1)
- OPGEN INC (3)
- Ophthotech Corp. (3)
- Opko Health, Inc. (3)
- ORAGENICS INC (1)
- Organicell Regenerative Medicine, Inc. (3)
- Organogenesis Holdings Inc. (1)
- Orgenesis Inc. (4)
- Outlook Therapeutics, Inc. (3)
- Ovid Therapeutics Inc. (1)
- PDL BIOPHARMA, INC. (7)
- PIERIS PHARMACEUTICALS, INC. (4)
- POLARITYTE, INC. (6)
- PREDICTIVE TECHNOLOGY GROUP, INC. (1)
- PREMIER BIOMEDICAL INC (3)
- Propanc Biopharma, Inc. (1)
- Protagenic Therapeutics, Inc. (2)
- Protagonist Therapeutics, Inc (1)
- Protalix BioTherapeutics, Inc. (3)
- PTC THERAPEUTICS, INC. (3)
- RECURSION PHARMACEUTICALS, INC. (4)
- Rezolute, Inc. (1)
- RITTER PHARMACEUTICALS INC (1)
- ROCKET PHARMACEUTICALS, INC. (1)
- Sage Therapeutics, Inc. (4)
- Sarepta Therapeutics, Inc. (1)
- SELECTA BIOSCIENCES INC (1)
- SELLAS Life Sciences Group, Inc. (1)
- Sesen Bio, Inc. (2)
- Social Capital Suvretta Holdings Corp. III (1)
- Sorrento Therapeutics, Inc. (2)
- Spectrum Pharmaceuticals, Inc. (6)
- Spero Therapeutics, Inc. (1)
- SPHERIX INC (2)
- Spring Bank Pharmaceuticals, Inc. (2)
- Stellar Biotechnologies, Inc. (1)
- Summit Therapeutics Inc. (1)
- Sun BioPharma, Inc. (1)
- Syndax Pharmaceuticals Inc (1)
- Synthetic Biologics, Inc. (1)
- TG THERAPEUTICS, INC. (3)
- Tonix Pharmaceuticals Holding Corp. (1)
- TYME TECHNOLOGIES, INC. (1)
- United Therapeutics Corp (1)
- USA EQUITIES CORP. (1)
- VACCINEX, INC. (2)
- Vaxart, Inc. (1)
- Verastem, Inc. (8)
- Vericel Corp (1)
- Vertex Pharmaceuticals Inc (4)
- VistaGen Therapeutics, Inc. (3)
- VITAL THERAPIES INC (1)
- VITRO DIAGNOSTICS INC (1)
- vTv Therapeutics Inc. (2)
- WINDTREE THERAPEUTICS INC (1)
- Xenetic Biosciences, Inc. (1)
- Xenon Pharmaceuticals Inc. (1)
- XOMA Corp (11)
- YIELD10 BIOSCIENCE, INC. (1)
- ZAFGEN, INC. (2)
- Zymeworks Inc. (2)
- Exchange Agreement, dated May 1, 2023, by and among ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P (IMMUNOGEN INC, Filed With SEC on May 2, 2023)
- Modification and Exchange Agreement (Allarity Therapeutics, Inc., Filed With SEC on April 25, 2023)
- Form of Exchange Agreement dated as of March 28, 2023 between the Company and the holder of the Exchange Securities (Kiromic Biopharma, Inc., Filed With SEC on March 31, 2023)
- Form of Exchange Agreement (Sarepta Therapeutics, Inc., Filed With SEC on March 3, 2023)
- Employment Agreement, effective as of February 28, 2023, by and between the Company and Kevin G. Shaw (Exhibits and schedules have been omitted pursuant to Item 601 of Regulation... (NextCure, Inc., Filed With SEC on March 2, 2023)
- Fifth Amendment to Lease Agreement, dated November 28, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (Exhibits and schedules have been omitted... (NextCure, Inc., Filed With SEC on March 2, 2023)
- Third Amendment to License Agreement and SRA, dated as of September 14, 2022, by and between the Company and Yale University. (Exhibits and schedules have been omitted pursuant to... (NextCure, Inc., Filed With SEC on March 2, 2023)
- Fourth Amendment to Lease Agreement, dated June 10, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (Exhibits and schedules have been omitted... (NextCure, Inc., Filed With SEC on March 2, 2023)
- Form of Purchase and Exchange Agreement (Invitae Corp, Filed With SEC on March 1, 2023)
- Exchange Agreement, dated January 17, 2023, by and among Cullinan Oncology, Inc. and the Stockholders named therein (Cullinan Oncology, LLC, Filed With SEC on January 19, 2023)
- Exchange Agreement, dated November 4, 2022, by and among Verastem, Inc. and the Stockholders named therein (Verastem, Inc., Filed With SEC on November 7, 2022)
- Agreement and Plan of Exchange, dated August 1, 2021, by and among Infinivive MD, LLC, Jack Zamora, its Sole Member, and the Registrant (VITRO DIAGNOSTICS INC, Filed With SEC on September 9, 2022)
- Restated and Amended Transaction Agreement, dated August 18, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo (Zymeworks Inc., Filed With SEC on August 19, 2022)
- Form of Exchange Agreement for the 2026 Notes (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 19, 2022)
- Securities Exchange Agreement between the Company and Astonia LLC (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Securities Exchange Agreement between the Company and EF2T, Inc (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Securities Exchange Agreement between the Company and EFT Holdings, Inc (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Securities Exchange Agreement between the Company and William E. Sluss (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Securities Exchange Agreement between the Company and Newlan & Newlan, Ltd (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Securities Exchange Agreement between the Company and Fabian G. Deneault (Digital Development Partners, Inc., Filed With SEC on August 15, 2022)
- Amendment to Safety Data Exchange Agreement, dated July 1, 2022, between ICPT Inc. and Mercury Pharma (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 3, 2022)
- Safety Data Exchange Agreement, dated May 5, 2022, between ICPT Inc. and Mercury Pharma (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 3, 2022)
- Form of Exchange Agreement (Apellis Pharmaceuticals, Inc., Filed With SEC on August 2, 2022)
- Form of Exchange Agreement (Apellis Pharmaceuticals, Inc., Filed With SEC on July 27, 2022)
- Exchange Agreement, dated as of July 11, 2022, by and among ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), ProKidney LP, acting through its... (Social Capital Suvretta Holdings Corp. III, Filed With SEC on July 15, 2022)
- Transaction Agreement, dated July 14, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo (Zymeworks Inc., Filed With SEC on July 15, 2022)
- Second Amendment to Share Exchange Agreement by and between AiPharma Group Ltd. and Aditxt, Inc. dated June 10, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on June 16, 2022)
- Amendment to Share Exchange Agreement by and between AiPharma Group Ltd. and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
- Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey (Immune Therapeutics, Inc., Filed With SEC on March 18, 2022)
- Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UMC-131, UMC-139)... (HEAT BIOLOGICS, INC., Filed With SEC on March 11, 2022)
- Second Amendment to License Agreement and SRA, dated as of October 20, 2021, by and between the Company and Yale University. (**Exhibits and schedules have been omitted pursuant... (NextCure, Inc., Filed With SEC on March 3, 2022)
- Employment Agreement, effective as of January 11, 2021, by and between the Company and Han Myint, M.D. (**Exhibits and schedules have been omitted pursuant to Item 601 of... (NextCure, Inc., Filed With SEC on March 3, 2022)
- Second Amendment to Lease Agreement, dated February 19, 2020, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (**Exhibits and schedules have been omitted... (NextCure, Inc., Filed With SEC on March 3, 2022)
- Third Amendment to Lease Agreement, dated February 4, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (**Exhibits and schedules have been omitted... (NextCure, Inc., Filed With SEC on March 3, 2022)
- Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein (Novus Therapeutics, Inc., Filed With SEC on January 13, 2022)
- Share Exchange Agreement dated as of December 28, 2021 by and between AiPharma Group Ltd. and Aditxt, Inc (ADiTx Therapeutics, Inc., Filed With SEC on December 28, 2021)
- Form of Exchange Agreement between Marizyme, Inc. and the person executing the signature page thereto (MARIZYME INC, Filed With SEC on December 27, 2021)
- Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc. and the Netherlands Cancer Institute, Amsterdam, and Oncode Institute, Utrecht, entered into... (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on November 10, 2021)
- Form of Exchange Agreement (Organicell Regenerative Medicine, Inc., Filed With SEC on November 2, 2021)
- Exchange Agreement, dated as of October 22, 2021, between the Company and Crossover Capital Fund I, LLC (BioRestorative Therapies, Inc., Filed With SEC on October 29, 2021)